Trials / Completed
CompletedNCT02624050
Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs
Comparison of Methohexital With Propofol for Anesthetic Induction in Patients Treated With an Antagonist of the Renin-Angiotensin System.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Patient undergoing general anesthesia in elective surgery will be assigned to receive either methohexital or propofol general anesthesia. Hypotensive events during the first 15 minutes of induction will be compared between the groups to ascertain which drug is less likely to cause a hypotensive event.
Detailed description
Patients taking angiotensin converting-enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are susceptible to hypotensive events during general anesthesia. The purpose of this study is to determine if the use of either methohexital or propofol general anesthesias is more likely to result in hypotensive events in these patients during their induction. Hemodynamic metrics like blood pressure, mean arterial pressure, and heart rate will be monitored during the induction process, under both drugs, for use as the main metrics, as well as the need for vasopressors in response to patient hypotension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methohexital | Both drugs of interest are standard of care for use as general anesthetics. The purpose of the study is the determine the susceptibility of both drugs to inducing a hypotensive event. |
| DRUG | Propofol | Both drugs of interest are standard of care for use as general anesthetics. The purpose of the study is the determine the susceptibility of both drugs to inducing a hypotensive event. |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2018-01-31
- Completion
- 2018-01-31
- First posted
- 2015-12-08
- Last updated
- 2025-01-28
- Results posted
- 2019-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02624050. Inclusion in this directory is not an endorsement.